{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["200(3)"],"submitter":["Majewski W"],"pubmed_abstract":["<h4>Purpose</h4>Local recurrences after radical prostatectomy (RP) and postoperative radiotherapy (RT) are challenging for salvage treatment. Retrospective analysis of own experiences with salvage re-irradiation was performed.<h4>Methods</h4>The study included all consecutive patients treated with salvage stereotactic body radiotherapy (sSBRT) for prostate bed recurrence following RP and postoperative RT at a single tertiary center between 2014 and 2021. Treatment toxicity defined as the occurrence of CTCAE grade ≥ 2 genito-urinary (GU) or gastro-intestinal (GI) adverse events (AEs) was assessed. A PSA response, biochemical control (BC) and overall survival (OS) were also evaluated.<h4>Results</h4>The study group included 32 patients with a median age of 68 years and a median follow-up of "],"journal":["Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]"],"pagination":["230-238"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10876733"],"repository":["biostudies-literature"],"pubmed_title":["Stereotactic body radiotherapy (SBRT) re-irradiation for local failures following radical prostatectomy and post-operative radiotherapy."],"pmcid":["PMC10876733"],"pubmed_authors":["Graupner D","Goc B","Goldner G","Napieralska A","Majewski W","Miszczyk M"],"additional_accession":[]},"is_claimable":false,"name":"Stereotactic body radiotherapy (SBRT) re-irradiation for local failures following radical prostatectomy and post-operative radiotherapy.","description":"<h4>Purpose</h4>Local recurrences after radical prostatectomy (RP) and postoperative radiotherapy (RT) are challenging for salvage treatment. Retrospective analysis of own experiences with salvage re-irradiation was performed.<h4>Methods</h4>The study included all consecutive patients treated with salvage stereotactic body radiotherapy (sSBRT) for prostate bed recurrence following RP and postoperative RT at a single tertiary center between 2014 and 2021. Treatment toxicity defined as the occurrence of CTCAE grade ≥ 2 genito-urinary (GU) or gastro-intestinal (GI) adverse events (AEs) was assessed. A PSA response, biochemical control (BC) and overall survival (OS) were also evaluated.<h4>Results</h4>The study group included 32 patients with a median age of 68 years and a median follow-up of ","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Mar","modification":"2026-06-17T06:29:19.599Z","creation":"2025-04-05T23:49:32.726Z"},"accession":"S-EPMC10876733","cross_references":{"pubmed":["38157016"],"doi":["10.1007/s00066-023-02187-2"]}}